• Flubendazole: Applied Autophagy Modulation in Cancer Biology

  2026-06-11

  Flubendazole (methyl N-[6-(4-fluorobenzoyl)-1H-benzimidazol-2-yl]carbamate) enables reproducible autophagy modulation in advanced cancer biology and neurodegenerative disease research. This article delivers workflow-anchored guidance, protocol optimizations, and troubleshooting tips for maximizing Flubendazole’s utility in cell-based studies.

• Mechanistic Precision in qPCR: Rethinking Biomarker Discover

  2026-06-11

  This article explores the strategic integration of HotStart Universal 2X FAST Green qPCR Master Mix (Rox) into translational research workflows, with a focus on biomarker validation exemplified by AKTIP in fibrolamellar carcinoma. By weaving together mechanistic insights, experimental rigor, and competitive analysis, it guides researchers on achieving reproducible, high-specificity gene expression analysis, even in challenging clinical samples.

• Ferroptosis-Related Gene Signature and Atorvastatin in HCC P

  2026-06-10

  This study introduces a novel four-gene ferroptosis-related prognostic model for hepatocellular carcinoma (HCC) and identifies atorvastatin as a potential therapeutic agent that induces ferroptosis in HCC cells. The findings advance both prognostic stratification and therapeutic targeting of ferroptosis in liver cancer, with practical implications for experimental design in oncology research.

• ML-7 Hydrochloride: Applied Workflows in MLCK Inhibitor Rese

  2026-06-10

  ML-7 hydrochloride enables precise inhibition of myosin light chain kinase, unlocking advanced experimental workflows in cardiovascular and cancer models. This guide details stepwise protocols, key troubleshooting tips, and practical insights based on quantitative literature, ensuring reliable use of this selective MLCK inhibitor for translational discoveries.

• Cy5.5 NHS Ester (Non-Sulfonated): Transforming Tumor Microbi

  2026-06-09

  Explore how Cy5.5 NHS ester (non-sulfonated) is advancing near-infrared microbiome imaging in cancer research. This article reveals unique assay strategies, protocol nuances, and cross-domain implications that go beyond traditional protein conjugation applications.

• Doxycycline Hyclate: Strategic MMP Inhibition for Neurovascu

  2026-06-09

  This thought-leadership article examines the mechanistic and translational impact of doxycycline hyclate as a matrix metalloproteinases inhibitor, spotlighting its role in protecting blood-brain barrier integrity and mitigating arsenic-induced neurotoxicity. Integrating evidence from recent in vivo studies, we provide actionable guidance for translational researchers seeking to leverage doxycycline hyclate’s unique properties in neurovascular and cognitive impairment models, while contextualizing its broader competitive and experimental landscape.

• Modeling Human SAN-Neural Interactions with PSC-Derived Asse

  2026-06-08

  This study introduces a tri-assembloid system combining human pluripotent stem cell-derived sinoatrial node, cardiac plexus, and atrial organoids to recapitulate neuro-cardiac interactions driving pacemaker maturation. The model enables functional analysis of neuron-to-pacemaker signaling and provides a new human-specific platform for investigating SAN development and conduction disorders.

• Atropo-Enantioselective Suzuki Coupling Yields Axially Chira

  2026-06-08

  This study demonstrates a pioneering catalytic asymmetric synthesis of axially chiral biaryl analogues of (-)-rhazinilam using an atropo-enantioselective Suzuki cross-coupling. The method enables precise control over axial chirality, which is crucial for biological activity, and sets a new standard for the synthesis of biaryl natural products and analogues with antimitotic properties.

• miR-18a/ALOXE3 Axis Regulates Ferroptosis in Glioblastoma

  2026-06-07

  This study reveals that miR-18a directly suppresses ALOXE3, reducing ferroptotic and anti-migratory activities in glioblastoma cells. The findings highlight the miR-18a/ALOXE3 axis as a molecular driver of glioblastoma progression and a potential therapeutic target.

• Perospirone (SM-9018 Free Base): Experimental Strategies in

  2026-06-06

  Perospirone (SM-9018 freebase) uniquely bridges classical antipsychotic pharmacology with cutting-edge vascular ion channel research. This article guides researchers through experimental workflows, troubleshooting advice, and translational insights for leveraging Perospirone in advanced neuropsychiatric and cardiovascular models.

• Hesperadin as a Quantitative Tool: Decoding Aurora B Functio

  2026-06-05

  Explore how Hesperadin, a potent Aurora B kinase inhibitor, enables quantitative dissection of mitotic checkpoint disassembly and chromosome segregation. This article offers a deep-dive into mechanistic insights, unique protocol strategies, and new perspectives for cancer research.

• YTHDF2 Inhibition Enhances Hippocampal Memory via m6A mRNA S

  2026-06-05

  The referenced study reveals that forebrain-specific knockout of YTHDF2, an m6A reader protein, enhances protein synthesis and hippocampus-dependent memory by stabilizing m6A-modified mRNAs. These findings highlight the pivotal role of m6A-mediated mRNA degradation in synaptic plasticity and cognitive processes, offering new avenues for neuroepigenetic research.

• U0126-EtOH: Selective MEK1/2 Inhibitor for MAPK/ERK Modulati

  2026-06-04

  U0126-EtOH is a potent, selective MEK1/2 inhibitor widely used for dissecting MAPK/ERK signaling. It demonstrates nanomolar inhibition in vitro and effectively blocks ERK phosphorylation in neuronal and inflammatory models. This article details validated applications, protocol parameters, and limitations, supporting confident use in oxidative stress and inflammation research.

• SM-164: Bivalent Smac Mimetic for Precision Apoptosis Induct

  2026-06-04

  SM-164, a bivalent Smac mimetic from APExBIO, enables rapid and selective apoptosis induction in tumor models by targeting cIAP-1/2 and XIAP. This guide distills practical workflows, protocol optimization, and troubleshooting for leveraging SM-164 in advanced cancer research, bridging new mechanistic insights and robust experimental performance.

• Promethazine HCl: Redefining Host-Directed Antibacterial Res

  2026-06-03

  This article explores the cutting-edge roles of promethazine hydrochloride (Promethazine HCl) in translational immunology, focusing on its unique mechanistic actions in macrophage antibacterial defense. By integrating recent experimental findings, strategic guidance, and competitive insights, we chart the future for researchers leveraging this phenothiazine derivative in host-directed therapy, inflammation research, and advanced neuroscience models.

407 records 12/28 page Previous Next First page 上5页 1112131415 下5页 Last page